ContextVision AB
The answer first
Does ContextVision beat the market?
No, ContextVision has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 91% of Nordic stocks
- Quality89
- Value41
- Trend89
No. 10 of 195 in healthcare
Expectations in the price
Low expectations
For the share to return about 9% a year from today's price, it is enough that the cash ContextVision keeps stays flat for 10 years.
Max for seven days
Follow ContextVision with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about ContextVision
Your first answer is free, no account needed.
Do you own ContextVision, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with ContextVision and a few more. Free, no card.
Super Stock+44.6%In short
- ContextVision has risen 15.3% over the past year, including dividends.
- Overall, ContextVision ranks better than 91% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 79.7%. The price is 85.1% below its peak now.
What do analysts think of ContextVision?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 91% of Nordic stocks.
No. 10 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 37 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.19
- Asset turnoverSales divided by everything the company owns0.94
- Return on equityProfit divided by equity+17.5%
- Cash conversionOperating cash flow divided by profit1.42
The ranking is built on equity ratio, ROA and how steadily profit grows.
Medium Fair price: about the same as a typical Nordic stock.
No. 59 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity3.0
- P/SPrice divided by sales2.5
- P/EPrice divided by earnings17.3
- P/CFPrice divided by operating cash flow12.2
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 25 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+12.7%
- 6 months+19.4%
- 9 months+21.2%
- 12 months+15.3%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About ContextVision
ContextVision AB is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 42 employees.
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women's health, veterinary medicine, and point of-care applications.


See the full analysis of ContextVision.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card